Nasus Pharma Ltd

Research Nasus Pharma Ltd (NSRX) on Bullrun: market cap USD 40.40M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNSRX
• ExchangeNYSE MKT
• CountryIsrael
• SectorHealthcare
• IndustryDrug Manufacturers-General
• CurrencyUSD
• Market capUSD 40.40M
• Financial periodFY2025
• RevenueUSD 1.24B
• Net income-USD 5.86M
• Free cash flow-USD 4.93M

Valuation Snapshot

latest market cap is USD 40.40M.

About Nasus Pharma Ltd

Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose. Nasus Pharma Ltd.

Frequently asked questions

What is Nasus Pharma Ltd's market cap?

Nasus Pharma Ltd's market capitalization is USD 40.40M.

What does Nasus Pharma Ltd do?

Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats.